Skip to content

R&D at other companies

Oracle logo
OracleORCL
$2.61B-1.5%
Solventum logo
SolventumSOLV
$189M-2.1%
Waystar Holding Corp. logo
Waystar Holding Corp.WAY
$18.37M+65.8%
Phreesia logo
PhreesiaPHR
$28.33M-11.0%
Flywire Corporation logo
Flywire CorporationFLYW
$19.43M+14.9%
Teladoc Health logo
Teladoc HealthTDOC
$67.87M-3.0%

Segments

By segment

See full
Patient Care$4.26M-13.5%
Financial Health$3.06M-1.5%

Other financials

Income statement

See full
Revenue$86.3M-1.1%
Gross profit$47.9M+0.5%
Operating income$3.1M-62.5%
Net income$506.0K+10.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$35.4M+250%
Total debt$168.5M-1.4%
Total equity$178.7M+7.1%
Total assets$407.5M+4.8%

Cash flow

See full
Operating cash flow$15.5M+168%
CapEx$1.1M+201%
Free cash flow$14.4M+166%

Valuation

See full
Market cap$392.68M+16.7%
Enterprise value$525.72M+5.7%
P/E42.9×
P/S1.1×+0.2×

Profitability

See full
Gross margin53.2%+1.5pp
Operating margin4.5%+0.2pp
Net margin0.9%+0.5pp
FCF margin12.9%+2.2pp

Returns & leverage

See full
Return on equity1.8%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by TruBridge, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: TruBridge, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about TruBridge, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TruBridge, Inc.'s R&D?
TruBridge, Inc. (TBRG) reported R&D of $7.45M in Q1 2026.
How has TruBridge, Inc.'s R&D changed year-over-year?
TruBridge, Inc.'s R&D decreased by 9.7% year-over-year, from $8.25M to $7.45M.
What is the long-term trend for TruBridge, Inc.'s R&D?
Over 4 years (2021 to 2025), TruBridge, Inc.'s R&D has grown at a -0.2% compound annual growth rate (CAGR), from $32.81M to $32.56M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.